Publication:
Analysis of Prevalence and Predictive Factors of Long-Lasting Olfactory and Gustatory Dysfunction in COVID-19 Patients.

dc.contributor.authorCallejón-Leblic, María A
dc.contributor.authorMartín-Jiménez, Daniel I
dc.contributor.authorMoreno-Luna, Ramón
dc.contributor.authorPalacios-Garcia, Jose M
dc.contributor.authorAlvarez-Cendrero, Marta
dc.contributor.authorVizcarra-Melgar, Julissa A
dc.contributor.authorFernandez-Velez, Carlos
dc.contributor.authorReyes-Tejero, Isabel M
dc.contributor.authorMaza-Solano, Juan
dc.contributor.authorGonzalez-Garcia, Jaime
dc.contributor.authorTena-García, Beatriz
dc.contributor.authorAcosta-Mosquera, María E
dc.contributor.authorDel Cuvillo, Alfonso
dc.contributor.authorSánchez-Gómez, Serafín
dc.date.accessioned2023-05-03T14:13:06Z
dc.date.available2023-05-03T14:13:06Z
dc.date.issued2022-08-17
dc.description.abstractAlthough smell and taste disorders are highly prevalent symptoms of COVID-19 infection, the predictive factors leading to long-lasting chemosensory dysfunction are still poorly understood. 102 out of 421 (24.2%) mildly symptomatic COVID-19 patients completed a second questionnaire about the evolution of their symptoms one year after the infection using visual analog scales (VAS). A subgroup of 69 patients also underwent psychophysical evaluation of olfactory function through UPSIT. The prevalence of chemosensory dysfunction decreased from 82.4% to 45.1% after 12 months, with 46.1% of patients reporting a complete recovery. Patients older than 40 years (OR = 0.20; 95% CI: [0.07, 0.56]) and with a duration of loss of smell longer than four weeks saw a lower odds ratio for recovery (OR = 0.27; 95% CI: [0.10, 0.76]). In addition, 28 patients (35.9%) reported suffering from parosmia, which was associated with moderate to severe taste dysfunction at the baseline (OR = 7.80; 95% CI: [1.70, 35.8]). Among the 69 subjects who underwent the UPSIT, 57 (82.6%) presented some degree of smell dysfunction, showing a moderate correlation with self-reported VAS (r = -0.36, p = 0.0027). A clinically relevant number of subjects reported persistent chemosensory dysfunction and parosmia one year after COVID-19 infection, with a moderate correlation with psychophysical olfactory tests.
dc.identifier.doi10.3390/life12081256
dc.identifier.issn2075-1729
dc.identifier.pmcPMC9410278
dc.identifier.pmid36013436
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410278/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2075-1729/12/8/1256/pdf?version=1660739821
dc.identifier.urihttp://hdl.handle.net/10668/21404
dc.issue.number8
dc.journal.titleLife (Basel, Switzerland)
dc.journal.titleabbreviationLife (Basel)
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Jerez, Costa Noroeste y Sierra de Cáidz
dc.organizationAGS - Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectUPSIT
dc.subjectanosmia
dc.subjectolfactory disorders
dc.subjectparosmia
dc.subjectprediction model
dc.subjectsmell disorders
dc.subjectsmell test
dc.titleAnalysis of Prevalence and Predictive Factors of Long-Lasting Olfactory and Gustatory Dysfunction in COVID-19 Patients.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9410278.pdf
Size:
882.22 KB
Format:
Adobe Portable Document Format